Stockreport

Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 loss per share (vs US$1.84 loss in 3Q 2023) [Yahoo! Finance]

Lipella Pharmaceuticals Inc.  (LIPO) 
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to grow 97% p.a. on average during the next 3 years [Read more]